tiprankstipranks
Palvella Therapeutics (PVLA)
NASDAQ:PVLA

Palvella Therapeutics (PVLA) Similar Stocks

Compare
606 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Palvella Therapeutics
$19.22
$213.20M
41.22%
4 Buy
0 Hold
0 Sell
Strong Buy
Alnylam Pharma
$250.59
$32.49B
61.94%
15 Buy
3 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$68.25
$13.10B
31.10
-22.92%
18 Buy
5 Hold
0 Sell
Strong Buy
Regeneron
$700.33
$76.09B
18.29
-26.41%
16 Buy
3 Hold
1 Sell
Strong Buy
Vertex Pharmaceuticals
$484.24
$123.34B
12.59%
14 Buy
12 Hold
1 Sell
Moderate Buy
SAGE Therapeutics
$7.31
$439.59M
-67.07%
2 Buy
13 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
PVLA
Palvella Therapeutics
19.22
6.32
48.99%
ALNY
Alnylam Pharma
250.59
87.78
53.92%
BMRN
BioMarin Pharmaceutical
68.25
-21.72
-24.14%
REGN
Regeneron
700.33
-263.32
-27.33%
VRTX
Vertex Pharmaceuticals
484.24
57.46
13.46%
SAGE
SAGE Therapeutics
7.31
-14.94
-67.15%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis